Esperion Therapeutics, Inc. — Director's Dealing 2016

Jun 10, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Esperion Therapeutics, Inc. (ESPR)
CIK: 0001434868
Period of Report: 2016-06-09

Reporting Person: MCGOVERN MARK E (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-06-09	Stock Option (right to buy)	$17.75	A	8000	Acquired	2026-06-09	Common Stock (8000)	Direct

Footnotes

F1: The options vest in full on the earlier of (i) June 9, 2017 and (ii) the Issuer's next annual meeting of stockholders following June 9, 2016.